January 30, 2018
How does a genomic tumor board impact patient care?
The outcomes from a Mayo Clinic study published in Oncotarget found value in having an established genomic tumor board, and using genomics for certain patients. The experience of the Genomic Tumor Board has promoted an evolution in the practice according to Alan Bryce, M.D., a Mayo Clinic oncologist, and co-first author on the study. “There is an emerging […]
Tags: Alan Bryce, cancer, Center for Individualized Medicine, genetic testing, genomics, Jan Egan, Mayo Clinic Cancer Center, tumor